Robbins Geller To Lead Amgen Investors In $10B Tax Bill Suit
A New York federal judge has appointed Robbins Geller Rudman & Dowd LLP as lead counsel in a proposed class action alleging that biotech company Amgen Inc. hid $10 billion in...To view the full article, register now.
Already a subscriber? Click here to view full article